Biomanufacturing Media

31. How End Users Can Drive Single-Use Harmonization 9/12/2025

    Though progress has been made in supplier-created standards, broader harmonization is difficult to balance in a competitive supplier market. In this segment from the Bioprocess Online Live event, “Single-Use Harmonization Needs A Tune Up,” the panelists encourage self-regulation for the industry. This bottom-up approach, where standardization begins with end users, will ultimately put competitive pressure on suppliers.

32. Addressing Mismatched Connectors And Overcoming Validation Hurdles 9/12/2025

    During the Bioprocess Online Live event, “Single-Use Harmonization Needs A Tune Up,” audience members indicated mismatched connectors and validation challenges as their biggest pain points. In this segment, our panelists respond to the audience and weigh in on how to mitigate these difficulties.

33. Taking A Risk-Based Approach To Harmonization 9/12/2025

    In this segment from the Bioprocess Online Live event, “Single-Use Harmonization Needs A Tune Up,” our panelists a risk-based approach to standardizing SUS. They agree that a flexible strategy requires up-front pre-validation and pre-qualification, but it’s worth the initial investment.

34. Planning For Flexibility And Supply Chain Resilience 9/12/2025

    In this segment from the Bioprocess Online Live event, “Single-Use Harmonization Needs A Tune Up,” our panelists discuss the importance of working with your quality team to plan for flexibility, a lesson the industry learned the hard way during the COVID-19 supply chain disruptions.

35. Single-Use Standardization Starts Internally 9/12/2025

    We've all heard the expression: If you want to change the world, start at home. Single-use standardization is no different. In this segment from the Bioprocess Online Live event, “Single-Use Harmonization Needs A Tune Up,” our panelists Mark Petrich, Ph.D., and Frank Gillam, Ph.D., reflect on their success and struggles standardizing single-use systems within their respective organizations.

36. Nanoforming Biologics, GLP-1s: From I.V. To Sub Q And Inhaled Delivery 9/9/2025

    Developing new delivery routes is essential for creating more effective treatments. Nanoforming enables new routes to simplify dosing, enhance patient comfort, and reduce healthcare costs.

37. How CRISPR And LNP Accelerate Therapeutic Innovation Through Analytics 9/2/2025

    CRISPR gene editing and lipid nanoparticle delivery are revolutionizing precision medicine. Discover how optimized LNP systems and advanced analytics accelerate therapeutic development.

38. Overcoming Challenges In Ophthalmic Formulations 8/27/2025

    Discover key strategies for overcoming formulation challenges in ophthalmic drug development and learn how selecting the right excipients supports quality, compliance, and safety.

39. Developing An In Vivo CAR-T With Interius BioTherapeutics' Sianny Christanti and Babu Medi, Ph.D. 8/12/2025

    On this episode of Better Biopharma, Interius BioTherapeutics’ Sianny Christanti and Babu Medi, Ph.D., explain how the company is re-engineering a lentiviral vector to enable INT2104, its off-the-shelf, in vivo CAR T-cell therapy. They discuss the vector's design and its manufacturability, as well as the analytical and regulatory challenges of bringing this first-in-human therapy to the clinic.

40. Secure Your Sensitive Drug Substances 8/7/2025

    Explore the risks of freeze and thaw cycles on biological products and how an advanced plate freezing platform protects sensitive molecules with precision and ease.